+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07610642

Amnioinfusion During Labor to Protect Newborns Brains in Chorioamnionitis A Randomized Clinical Trial

Led by Medical College of Wisconsin · Updated on 2026-10-26

80

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying whether a treatment called amnioinfusion during labor can help protect the brains of newborns whose mothers have an infection called chorioamnionitis. This condition can cause inflammation and fever in the mother, which may stress the baby and lead to brain injury. The study is designed to test if amnioinfusion can reduce early brain injury markers measured at birth. Participants will be randomly assigned to receive either standard labor care or amnioinfusion using room-temperature lactated Ringers solution. The amnioinfusion involves a 500 mL fluid bolus over 30 minutes through an intrauterine pressure catheter, followed by a continuous infusion until delivery or a total of 1L. Both groups will continue receiving standard infection treatments during labor. Throughout the study, researchers will collect umbilical cord blood at delivery to test for brain injury biomarkers like S100B and others. Additional outcomes measured include neonatal and maternal health, developmental screening up to one year after birth, and healthcare use for mothers and children. The study lasts from labor through one year postpartum, tracking safety and developmental results.

CONDITIONS

Brief Title

Amnioinfusion for Chorioamnionitis: Targeting Neonatal Brain Injury Biomarkers

Research Team

B

Brock E Polnaszek, MD,MPH

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here